[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-31445":3,"doc-seo-31445":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":4,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"page_count":20,"language":21,"language_code":22,"table_of_contents":23,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},31445,8796095461610,"Oliver","https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",7,"Healthcare","How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice","Axial spondyloarthritis management benefits from periodic, quantitative disease activity assessment rather than reliance on clinical gestalt. The review evaluates validated generic and axSpA-specific instruments, summarizes a survey of rheumatologists and SPARTAN members on real-world measurement practices, and outlines strategies to improve monitoring with technological advances. It also clarifies definitions of active disease and treatment targets, highlighting guideline-supported measures such as BASDAI and ASDAS and the role of CRP-based ASDAS calculations.","cbCaiglCBa97G290","https://ap.wps.com/l/cbCaiglCBa97G290","pdf",621725,1,8,"English","en","# Abstract and Purpose\n# Available Disease Activity Measures\n## Guideline Recommendations (ACR/SAA/SPARTAN, ASAS-EULAR)\n# Recent Findings and Tools\n## Core Variable Set and OMERACT Endorsement\n## PROMIS and Semi-Objective Indices\n# Summary and Clinical Implementation\n## Shared Decision-Making and Digital Data Capture","[{\"question\":\"Why is periodic, quantitative monitoring preferred over clinical gestalt in axSpA?\",\"answer\":\"Guideline logic in the review supports better outcomes when treatment is guided by periodic quantitative data rather than subjective clinical impression.\"},{\"question\":\"Which validated instruments are recommended for regular disease activity monitoring?\",\"answer\":\"The review highlights BASDAI and ASDAS, with ASAS-EULAR guidance preferring ASDAS calculated with CRP.\"},{\"question\":\"How can technology improve disease activity assessment in routine clinical practice?\",\"answer\":\"Integration of electronic health records and smart devices can automate capture of ePROMs, enabling consistent regular monitoring and supporting long-term outcomes.\"}]",1779483718,20,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":22,"slug":31,"title":13,"keywords":32,"description":14,"schema_data":33,"social_meta":84,"head_meta":86,"extra_data":88,"updated_unix":25},105,"how-to-monitor-disease-activity-of-axial-spondyloarthritis-in-clinical-practice","",{"@graph":34,"@context":83},[35,52,66],{"@type":36,"itemListElement":37},"BreadcrumbList",[38,42,46,49],{"item":39,"name":40,"@type":41,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":43,"name":44,"@type":41,"position":45},"https://docshare.wps.com/document/","Document",2,{"item":47,"name":12,"@type":41,"position":48},"https://docshare.wps.com/document/healthcare/",3,{"item":50,"name":13,"@type":41,"position":51},"https://docshare.wps.com/document/how-to-monitor-disease-activity-of-axial-spondyloarthritis-in-clinical-practice/31445/",4,{"url":50,"name":13,"@type":53,"author":54,"headline":13,"publisher":56,"fileFormat":59,"description":14,"dateModified":60,"datePublished":60,"encodingFormat":59,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":55},"Person",{"url":39,"name":57,"@type":58},"DocShare","Organization","application/pdf","2026-05-22",true,{"@type":63,"interactionType":64,"userInteractionCount":4},"InteractionCounter",{"@type":65},"ViewAction",{"@type":67,"mainEntity":68},"FAQPage",[69,75,79],{"name":70,"@type":71,"acceptedAnswer":72},"Why is periodic, quantitative monitoring preferred over clinical gestalt in axSpA?","Question",{"text":73,"@type":74},"Guideline logic in the review supports better outcomes when treatment is guided by periodic quantitative data rather than subjective clinical impression.","Answer",{"name":76,"@type":71,"acceptedAnswer":77},"Which validated instruments are recommended for regular disease activity monitoring?",{"text":78,"@type":74},"The review highlights BASDAI and ASDAS, with ASAS-EULAR guidance preferring ASDAS calculated with CRP.",{"name":80,"@type":71,"acceptedAnswer":81},"How can technology improve disease activity assessment in routine clinical practice?",{"text":82,"@type":74},"Integration of electronic health records and smart devices can automate capture of ePROMs, enabling consistent regular monitoring and supporting long-term outcomes.","https://schema.org",{"og:url":50,"og:type":85,"og:title":13,"og:site_name":57,"og:description":14},"article",{"robots":87,"canonical":50},"index,follow",{"doc_id":7,"site_id":30}]